BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23844375)

  • 1. Advances in murine models of diabetic nephropathy.
    Kong LL; Wu H; Cui WP; Zhou WH; Luo P; Sun J; Yuan H; Miao LN
    J Diabetes Res; 2013; 2013():797548. PubMed ID: 23844375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental diabetic animal models to study diabetes and diabetic complications.
    Athmuri DN; Shiekh PA
    MethodsX; 2023 Dec; 11():102474. PubMed ID: 38023309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in animal models of diabetic nephropathy.
    Betz B; Conway BR
    Nephron Exp Nephrol; 2014; 126(4):191-5. PubMed ID: 25034792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rodent animal models: from mild to advanced stages of diabetic nephropathy.
    Kaur M; Bedi O; Sachdeva S; Reddy BV; Kumar P
    Inflammopharmacology; 2014 Oct; 22(5):279-93. PubMed ID: 25149089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of diabetic kidney disease.
    Gosmanov AR; Wall BM; Gosmanova EO
    Am J Med Sci; 2014 May; 347(5):406-13. PubMed ID: 24553399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of diabetic neuropathy: progress since 1960s.
    Islam MS
    J Diabetes Res; 2013; 2013():149452. PubMed ID: 23984428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid mediators in diabetic nephropathy.
    Srivastava SP; Shi S; Koya D; Kanasaki K
    Fibrogenesis Tissue Repair; 2014; 7():12. PubMed ID: 25206927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.
    Lee SY; Choi ME
    Pediatr Nephrol; 2015 Jul; 30(7):1063-75. PubMed ID: 25060761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High glucose forces a positive feedback loop connecting Akt kinase and FoxO1 transcription factor to activate mTORC1 kinase for mesangial cell hypertrophy and matrix protein expression.
    Das F; Ghosh-Choudhury N; Dey N; Bera A; Mariappan MM; Kasinath BS; Ghosh Choudhury G
    J Biol Chem; 2014 Nov; 289(47):32703-16. PubMed ID: 25288788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic kidney disease: from epidemiology to clinical perspectives.
    Park CW
    Diabetes Metab J; 2014 Aug; 38(4):252-60. PubMed ID: 25215271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of diabetic kidney disease.
    Reidy K; Kang HM; Hostetter T; Susztak K
    J Clin Invest; 2014 Jun; 124(6):2333-40. PubMed ID: 24892707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular disease: looking beyond pathology.
    Wiggins RC; Alpers CE; Holzman LB; He JC; Salant DJ; Chugh SS; Natarajan R; Trachtman H; Brasile L; Star RA; Rys-Sikora KE; Moxey-Mims MM; Flessner MF;
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1138-40. PubMed ID: 24700796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy, a targeted treatment for diabetic nephropathy.
    Lin X; Tao L; Tang D
    Curr Med Chem; 2013; 20(30):3774-84. PubMed ID: 23895680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models for type 1 and type 2 diabetes: advantages and limitations.
    Singh R; Gholipourmalekabadi M; Shafikhani SH
    Front Endocrinol (Lausanne); 2024; 15():1359685. PubMed ID: 38444587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rodent models of arteriovenous fistula.
    Li Y; Hu K; Li Y; Lu C; Guo Y; Wang W
    Front Cardiovasc Med; 2024; 11():1293568. PubMed ID: 38304139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current advancement in the preclinical models used for the assessment of diabetic neuropathy.
    Saini T; Mazumder PM
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2727-2745. PubMed ID: 37987794
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.